2-(2,4-Dioxy-1,2,3,4-Tetrahydropyrimidin-1-yl)-N-(4-Phenoxyphenyl)-Acetamides as a Novel Class of Cytomegalovirus Replication Inhibitors

Por Babkov, D. A., Paramonova, M. P., Ozerov, A. A., Khandazhinskaya, A. L., Snoeck, R., Andrei, G., Novikov, M. S.
Publicado no Acta Naturae (2015)

1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues – Novel Inhibitors of Human Adenovirus Replication

Por Nikitenko, N. A., Gureeva, E. S., Ozerov, A. A., Tukhvatulin, A. I., Izhaeva, F. M., Prassolov, V. S., Deryabin, P. G., Novikov, M. S., Logunov, D. Y.
Publicado no Acta Naturae (2018)

5-Arylaminouracil Derivatives as Potential Dual-Action Agents

Por Matyugina, E. S., Novikov, M. S., Babkov, D. A., Valuev-Elliston, V. T., Vanpouille, C., Zicari, S., Corona, A., Tramontano, E., Margolis, L. B., Khandazhinskaya, A. L., Kochetkov, S. N.
Publicado no Acta Naturae (2015)

Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System

Por Prokofjeva, M.M., Spirin, P.V., Yanvarev, D.V., Ivanov, A.V., Novikov, M.S., Stepanov, O.A., Gottikh, M.B., Kochetkov, S.N., Fehse, B., Stocking, C., Prassolov, V.S.
Publicado em 2011